InnovaRx Innova Health Strategies

C88.00

Waldenstrom macroglobulinemia not having achieved remission

Billable FY2026 2025-10-01 → 2026-09-30 FY2025–2027 only
Exclusions 3 never code together
C88.0code
Excludes1
  • small cell B-cell lymphoma (C83.0)C83.0
C88code
Excludes1
  • B-cell lymphoma, unspecified (C85.1-)C85.1-
  • personal history of other malignant neoplasms of lymphoid, hematopoietic and related tissues (Z85.79)Z85.79

Excludes1 — never code together. The excluded condition and this one are mutually exclusive.

Instructional notes 18
C88.00code
Inclusion terms
  • Lymphoplasmacytic lymphoma with IgM-production, NOS
  • Lymphoplasmacytic lymphoma with IgM-production not having achieved remission
  • Lymphoplasmacytic lymphoma with IgM-production with failed remission
  • Macroglobulinemia (idiopathic) (primary) NOS
  • Macroglobulinemia (idiopathic) (primary) not having achieved remission
  • Macroglobulinemia (idiopathic) (primary) with failed remission
  • Waldenström macroglobulinemia NOS
  • Waldenström macroglobulinemia with failed remission
C88.0code
Inclusion terms
  • Lymphoplasmacytic lymphoma with IgM-production
  • Macroglobulinemia (idiopathic) (primary)
C00-D49chapter
Notes
  • Functional activity
  • All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
  • Morphology [Histology]
  • Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
  • Primary malignant neoplasms overlapping site boundaries
  • A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
  • Malignant neoplasm of ectopic tissue
  • Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).C25.9
Index entries leading here 5
  • Disorder (of) — see also Disease
    • glomerular (in) N05.9
      • Waldenström macroglobulinemia C88.0
  • Glomerulonephritis N05.9
    • in (due to)
      • Waldenström macroglobulinemia C88.0
  • Lymphoma (of) (malignant) C85.90
    • lymphoplasmacytic C83.0
      • with IgM-production C88.0
  • Macroglobulinemia (idiopathic) (primary) C88.0
  • Waldenström
    • syndrome or macroglobulinemia C88.0
Alongside this code 1 same parent — C88.0
Medications 1

MED-RT files conditions by MeSH, which carves the world differently from ICD-10. These are name matches on this code's description, offered as candidates — not as an assertion that they are this code.

Additional references
AHA Coding Clinic® Licence required

Official coding advice for this code. Published by the American Hospital Association. Not included in this installation.

Risk adjustment

CMS22HCC23 CMS28HCC21 ESRD21HCC23 ESRD24HCC23 RX08HCC19

Presence is a property of the code. Untick a model to hide it everywhere.

This code

Billable
yes
Code set
FY2026
Parent
C88.0
Block
C00-C96
Siblings
1

Present FY2025–FY2027.